MPM BioImpact’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.9M | Sell |
2,282,680
-13,244
| -0.6% | -$45.8K | 1.37% | 34 |
|
|
2025
Q1 | $6.02M | Buy |
2,295,924
+27,099
| +1% | +$71K | 1.03% | 36 |
|
|
2024
Q4 | $9.35M | Buy |
2,268,825
+235,784
| +12% | +$971K | 1.33% | 33 |
|
|
2024
Q3 | $14.4M | Buy |
2,033,041
+758,582
| +60% | +$5.37M | 2.16% | 17 |
|
|
2024
Q2 | $8.31M | Buy |
1,274,459
+442,442
| +53% | +$2.88M | 1.29% | 31 |
|
|
2024
Q1 | $6.91M | Hold |
832,017
| – | – | 1.11% | 34 |
|
|
2023
Q4 | $9.16M | Sell |
832,017
-520,116
| -38% | -$5.73M | 2.14% | 21 |
|
|
2023
Q3 | $11.4M | Sell |
1,352,133
-2,235
| -0.2% | -$18.8K | 3.04% | 13 |
|
|
2023
Q2 | $17M | Buy |
1,354,368
+128,734
| +11% | +$1.62M | 3.43% | 10 |
|
|
2023
Q1 | $20.2M | Buy |
+1,225,634
| New | +$20.2M | 5.24% | 7 |
|